Marisa Ionta¹

Dr. Marisa Ionta¹

Federal University of Alfenas, Alfenas, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DRDaniel Rodrigues
Daniel Rodrigues
GFGuilherme À. Ferreira-Silva
Guilherme À. Ferreira-Silva
AFAna C. S. Ferreira
Ana C. S. Ferreira
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
JKJolie K. Kwee
Jolie K. Kwee
Carlos FragaCarlos Fraga
Carlos Fraga

1 March 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FVFlávia Pereira Dias Viegas
Flávia Pereira Dias Viegas
MSMatheus de Freitas Silva
Matheus de Freitas Silva
MRMiguel Divino da Rocha
Miguel Divino da Rocha
MCMaísa Rosa Castelli
Maísa Rosa Castelli
MRMariana Máximo Riquiel
Mariana Máximo Riquiel
CJClaudio Viegas Jr.
Claudio Viegas Jr.

1 August 2018 in Toxicology in Vitro
Verified
Journal Article
Closed access
MSMatheus de Freitas Silva
Matheus de Freitas Silva
LCLetícia Ferreira Coelho
Letícia Ferreira Coelho
IGIsadora Mitestainer Guirelli
Isadora Mitestainer Guirelli
RPRodrigo Machado Pereira
Rodrigo Machado Pereira
GFGuilherme Álvaro Ferreira-Silva
Guilherme Álvaro Ferreira-Silva
CJClaudio Viegas Jr.
Claudio Viegas Jr.

1 September 2019 in Toxicology in Vitro
Verified
Journal Article
Closed access
HAHelloana Azevedo-Barbosa
Helloana Azevedo-Barbosa
GFGuilherme Álvaro Ferreira-Silva
Guilherme Álvaro Ferreira-Silva
CSCarolina Faria Silva
Carolina Faria Silva
TSThiago Belarmino de Souza
Thiago Belarmino de Souza
DDDanielle Dias
Danielle Dias
Diogo Teixeira CarvalhoDiogo Teixeira Carvalho
Diogo Teixeira Carvalho

1 March 2016 in Toxicology in Vitro
Verified
Journal Article
Closed access
RPRodrigo Machado Pereira
Rodrigo Machado Pereira
GFGuilherme Álvaro Ferreira-Silva
Guilherme Álvaro Ferreira-Silva
Marcos PivattoMarcos Pivatto
Marcos Pivatto
LSLuciana de Ávila Santos
Luciana de Ávila Santos
VBVanderlan Bolzani
Vanderlan Bolzani
MIMarisa Ionta
Marisa Ionta

30 October 2015 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LSLeilane Sales
Leilane Sales
JPJulia Pezuk
Julia Pezuk
KBKleiton Silva Borges
Kleiton Silva Borges
MBMaría Sol Brassesco
María Sol Brassesco
CSCarlos Alberto Scrideli
Carlos Alberto Scrideli
Jaqueline Carvalho de OliveiraJaqueline Carvalho de Oliveira
Jaqueline Carvalho de Oliveira
Glioblastoma is the most common tumor of the central nervous system and one of the hardest tumors to treat. Consequently, the search for novel therapeutic options is imperative. 7-epiclusianone, a tetraprenylated benzophenone isolated from the epicarp of the native plant Garcinia brasiliensis, exhibits a range of biological activities but its prospect anticancer activity is underexplored. Thus, the aim of the present study was to evaluate the influence of 7-epiclusianone on proliferation, clonogenic capacity, cell cycle progression and induction of apoptosis in two glioblastoma cell lines (U251MG and U138MG). Cell viability was measured by the MTS assay; for the clonogenic assay, colonies were stained with Giemsa and counted by direct visual inspection; For cell cycle analysis, cells were stained with propidium iodide and analyzed by cytometry; Cyclin A expression was determined by immunoblotting; Apoptotic cell death was determined by annexin V fluorescein isothiocyanate labeling and Caspase-3 activity in living cells. Viability of both cell lines was drastically inhibited; moreover, the colony formation capacity was significantly reduced, demonstrating long-term effects even after removal of the drug. 7-epiclusianone treatment at low concentrations also altered cell cycle progression, decreased the S and G2/M populations and at higher concentrations increased the number of cells at sub-G1, in concordance with the increase of apoptotic cells. The present study demonstrates for the first time the anticancer potential of 7-epiclusianone against glioblastoma cells, thus meriting its further investigation as a potential therapeutic agent.